Neugenesis Corporation

Neugenesis uses its propriety technologies to support its internal biopharmaceutical pipeline. In addition, Neugenesis contracts and licenses its proprietary technologies to industry clients working in non-competing areas. The Neugenesis technologies are simple, inexpensive, and elegant. They are the result of the company's ability to leverage fundamental biological research into commercial biotechnology applications.

Contact Details: 849 Mitten Road, Suite 102 Burlingame California 94010 United States of America Tel: 650-689-2220 Fax: Email: dstuart@neugenesis.com WWW: www.neugenesis.com/

Loading...

Recent Publications by Neugenesis Corporation:
Vaccine production in Neurospora crassa. We have chosen to use the filamentous fungus Neurospora crassa to produce...	14th August, 2009	Neugenesis Corporation, Burlingame, CA, USA.	Biologicals. 2009 Jun;37(3):128-32. Epub 2009 Mar 12. DOI Direct Link

Press Releases on Neugenesis Corporation:
Takeda San Francisco, Inc. Appoints Michael Buckley, Ph.D. Vice President of Process Sciences	12th October, 2009	Takeda San Francisco, Inc.	SAN FRANCISCO, Oct. 12 /PRNewswire/ -- Takeda San Francisco, Inc. announced today that Michael Buckley, Ph.D., has joined the company as vice president of process sciences. Dr. Buckley will be

BioNews Results for Neugenesis Corporation:
Takeda San Francisco, Inc. Appoints Michael Buckley, Ph.D. Vice President of Process Sciences	Pharma Live:  Oct 13 2009 12:43AM Matching: neugenesis
Takeda San Francisco, Inc. Appoints Michael Buckley, Ph.D. Vice President of Process Sciences	SmartBrief:  Oct 12 2009 8:31PM Matching: neugenesis
Takeda San Francisco, Inc. Appoints Michael Buckley, Ph.D. Vice President of Process Sciences	Montana's News Station:  Oct 12 2009 6:19PM Matching: neugenesis
Takeda San Francisco Appoints Michael Buckley, Ph.D. Vice President of Process Sciences	BioSpace:  Oct 12 2009 6:13PM Matching: neugenesis
Takeda San Francisco, Inc. Appoints Michael Buckley, Ph.D. Vice President of Process Sciences	Freshnews.com:  Oct 12 2009 5:53PM Matching: neugenesis
Promote your company here: BioNewsCast - Press Release Distribution	→View more Neugenesis Corporation news.

Neugenesis Corporation Patents:
US Patent No.	Title
7323299	Methods for in vivo diversification of single genes
6268140	Combinatorial metabolic libraries
5834191	Production of heterologous peptides

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 441 times since April 2007, the link to the organisation's website has been followed 51 times

Recent Search Terms used to find this page: biotech companies in san francisco bay area | has anyone tried neugenisis | .

Search for more companies in Burlingame

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Neugenesis Corporation